Advertisement
Screener

Opus Genetics, Inc. (IRD) Graph

IRD Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $755.00K; Revenue including tax (m); Research and development (m); Operating expenses $17.23M.
  • 2026-03-31: Revenue $2.16M; Revenue including tax (m); Research and development (m); Operating expenses $16.52M.
  • 2025-12-31: Revenue $3.87M*; Revenue including tax (m); Research and development (m); Operating expenses $15.32M*.
  • 2025-09-30: Revenue $3.08M; Revenue including tax (m); Research and development (m); Operating expenses $11.39M.

Type Of Arrangement

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

IRD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.RDH12Agreement$600.00KSBIR Grant Agreement$500.00KViatris LicenseAgreement$800.00KRevenue$755.00KOperating expenses$17.24MOperating income-$16.48MOther income, net$1.74MPre-tax income-$8.10MIncome tax$0.00Net income-$8.10M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesIncome taxNet income
2026-06-30$755.00K(m)(m)$17.23M$0.00-$8.10M
2026-03-31$2.16M(m)(m)$16.52M$0.00-$65.53M
2025-12-31$3.87M*(m)(m)$15.32M*$0.00*-$16.52M*
2025-09-30$3.08M(m)(m)$11.39M$0.00-$17.45M
2025-06-30$2.88M(m)(m)$11.79M$0.00-$7.42M
2025-03-31$4.37M(m)(m)$14.30M$0.00-$8.19M
2024-09-30$3.87M(m)(m)$11.88M$0.00-$7.53M
2024-06-30$1.11M(m)(m)$9.44M$0.00-$7.76M
2024-03-31$1.71M(m)(m)$9.42M$0.00-$7.11M
2023-09-30$11.94M(m)(m)$5.55M$14.00K$5.56M
2023-06-30$3.67M(m)(m)$9.06M$0.00-$4.96M
2023-03-31$1.75M(m)(m)$7.88M$0.00-$5.79M
2022-09-30$0.00(m)(m)$4.54M$0.00-$4.53M
2022-06-30$0.00(m)(m)$4.94M$0.00-$4.93M
2022-03-31$0.00(m)(m)$6.51M$0.00-$6.59M
2021-09-30$489.00K(m)(m)$4.72M$0.00-$4.23M
2021-06-30$100.00K(m)(m)$7.24M$0.00-$7.14M
2021-03-31(m)(m)(m)$5.19M$0.00-$39.01M
2020-09-30$0.00(m)$149.59K$1.95M$0.00-$1.25M
2020-06-30$0.00(m)$231.61K$1.26M$0.00-$1.60M
2020-03-31$1.15M(m)$456.79K$2.73M$0.00-$3.09M
2019-12-31(m)$0.00*(m)(m)(m)(m)
2019-09-30(m)(m)$1.13M$2.28M(m)-$1.96M
2019-06-30(m)(m)$1.65M$2.99M(m)-$2.46M
2019-03-31(m)$3.00M$2.24M$3.94M(m)-$2.34M
2018-12-31(m)(m)(m)$4.97M(m)-$3.12M
2018-09-30(m)(m)$2.89M$4.68M(m)-$5.34M
2018-06-30(m)(m)$3.43M$5.00M(m)-$3.84M
2018-03-31(m)(m)$4.06M$5.89M(m)-$2.07M
2017-12-31(m)(m)(m)$4.90M(m)-$3.59M
2017-09-30(m)(m)$2.64M$4.22M(m)-$1.04M
2017-06-30(m)(m)$2.54M$4.28M(m)$947.06K
2017-03-31(m)(m)$2.26M$3.95M(m)-$21.61M
2016-12-31(m)(m)(m)$3.92M(m)-$525.48K
2016-09-30(m)(m)$2.30M$3.72M(m)-$2.87M
2016-06-30(m)(m)$2.24M$3.91M(m)-$1.77M
2016-03-31(m)(m)$3.47M$4.86M(m)-$4.15M
2015-12-31(m)(m)(m)$4.37M(m)-$2.85M
2015-09-30(m)(m)$3.10M$4.66M(m)-$4.03M
2015-06-30(m)(m)$3.24M$4.82M(m)-$3.23M
2015-03-31(m)(m)$2.89M$4.42M(m)-$4.27M
2014-12-31(m)(m)(m)$3.85M(m)-$2.21M
2014-09-30(m)(m)$1.82M$3.14M(m)-$1.91M
2014-06-30(m)(m)$1.70M$3.51M(m)$194.46K
2014-03-31$0.00(m)$1.27M$2.77M$0.00-$14.60M
2013-12-31$0.00*(m)(m)(m)$0.00*(m)
2013-09-30$0.00(m)$781.28K$1.82M$0.00-$2.14M
2013-06-30$0.00(m)$925.13K$1.91M$0.00-$3.11M
2013-03-31$0.00(m)$552.47K$1.91M$0.00-$1.53M
2012-09-30$0.00(m)$1.07M$1.80M$0.00-$2.99M
2012-06-30$0.00(m)$1.02M$1.85M$0.00-$1.04M
2012-03-31$0.00(m)$1.04M$1.88M$0.00-$2.14M
2011-12-31$0.00*(m)(m)(m)$0.00*(m)
2011-09-30$0.00(m)$2.37M$3.36M$0.00-$1.47M
2011-06-30$0.00(m)$5.42M$6.46M$0.00-$5.83M
2011-03-31$0.00(m)$2.72M$3.91M$0.00-$4.44M
2010-09-30$0.00(m)$671.34K$2.37M$0.00$218.89K
2010-06-30$18.75K(m)$1.33M$3.21M$0.00-$3.60M

Revenue and expense 6 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesIncome taxNet income
2026-06-30$2.91M(m)(m)$33.76M$0.00-$73.63M
2025-06-30$7.25M(m)(m)$26.09M$0.00-$15.61M
2024-06-30$2.82M(m)(m)$18.86M$0.00-$14.87M
2023-06-30$5.42M(m)(m)$16.94M$0.00-$10.75M
2022-06-30$0.00(m)(m)$11.45M$0.00-$11.52M
2021-06-30$100.00K(m)(m)$12.42M$0.00-$46.15M
2020-06-30$0.00(m)$688.40K$4.00M$0.00-$4.69M
2019-06-30(m)$3.00M$3.89M$6.93M(m)-$4.81M
2018-06-30(m)(m)$7.49M$10.89M(m)-$5.91M
2017-06-30(m)(m)$4.81M$8.24M(m)-$20.66M
2016-06-30(m)(m)$5.71M$8.78M(m)-$5.91M
2015-06-30(m)(m)$6.13M$9.24M(m)-$7.51M
2014-06-30(m)(m)$2.97M$6.28M(m)-$14.41M
2013-06-30$0.00(m)$1.48M$3.82M$0.00-$4.64M
2012-06-30$0.00(m)$2.06M$3.73M$0.00-$3.18M
2011-06-30$0.00(m)$8.13M$10.37M$0.00-$10.27M
2010-06-30$37.50K(m)$1.82M$4.82M$0.00-$11.63M

Revenue and expense 9 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesIncome taxNet income
2025-09-30$10.33M(m)(m)$37.48M$0.00-$33.07M
2024-09-30$6.69M(m)(m)$30.73M$0.00-$22.40M
2023-09-30$17.36M(m)(m)$22.49M$14.00K-$5.19M
2022-09-30$0.00(m)(m)$15.98M$0.00-$16.05M
2021-09-30$589.00K(m)(m)$17.14M$0.00-$50.38M
2020-09-30$0.00(m)$837.99K$5.95M$0.00-$5.94M
2019-09-30(m)$3.00M$5.02M$9.21M(m)-$6.77M
2018-09-30(m)(m)$10.38M$15.57M(m)-$11.25M
2017-09-30(m)(m)$7.45M$12.46M(m)-$21.70M
2016-09-30(m)(m)$8.00M$12.49M(m)-$8.78M
2015-09-30(m)(m)$9.23M$13.90M(m)-$11.53M
2014-09-30(m)(m)$4.80M$9.42M(m)-$16.31M
2013-09-30$0.00(m)$2.26M$5.65M$0.00-$6.78M
2012-09-30$0.00(m)$3.13M$5.53M$0.00-$6.17M
2011-09-30$0.00(m)$10.51M$13.73M$0.00-$11.73M
2010-09-30$0.00(m)$2.45M$7.15M$0.00-$11.41M
2001-12-31(m)(m)(m)(m)(m)-$625.11K

Revenue and expense 12 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$14.20M(m)(m)(m)$52.80M$0.00-$49.59M
2024-12-31$10.99M(m)(m)(m)$73.07M$0.00-$57.53M
2023-12-31$19.05M(m)(m)(m)$29.61M$12.00K-$9.99M
2022-12-31$39.85M(m)(m)(m)$21.62M$315.00K$17.89M
2021-12-31$589.00K(m)(m)(m)$23.29M$0.00-$56.69M
2020-12-31$0.00(m)(m)(m)$19.97M$0.00-$24.62M
2019-12-31(m)$3.00M(m)$5.48M$4.19M$0.00-$6.17M
2018-12-31(m)(m)(m)$13.11M$20.54M(m)-$14.37M
2017-12-31(m)(m)(m)$10.72M$17.35M(m)-$25.29M
2016-12-31(m)(m)(m)$10.09M$16.41M(m)-$9.31M
2015-12-31(m)(m)(m)$12.15M$18.26M(m)-$14.38M
2014-12-31(m)(m)(m)$7.02M$13.27M(m)-$18.52M
2013-12-31$0.00(m)(m)$3.25M$7.98M$0.00-$9.50M
2012-12-31$0.00(m)(m)$3.39M$6.58M$0.00-$6.23M
2011-12-31$0.00(m)(m)$11.99M$16.13M$0.00-$11.34M
2010-12-31$0.00(m)(m)$3.93M$10.31M$0.00-$14.02M
2009-12-31$0.00(m)$100.00K$3.18M$6.47M$0.00-$2.90M
2008-12-31(m)(m)(m)(m)(m)(m)-$3.68M
2007-12-31(m)(m)(m)(m)(m)(m)-$4.44M
2006-12-31(m)(m)(m)(m)(m)(m)-$6.49M
2005-12-31(m)(m)(m)(m)(m)(m)-$6.35M
2004-12-31(m)(m)(m)(m)(m)(m)-$3.27M
2003-12-31(m)(m)(m)(m)(m)(m)-$2.78M
2002-12-31(m)(m)(m)(m)(m)(m)-$1.18M

Similar stocks

Stock NameCountryMarket CapPE Ratio
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Rezolute, Inc. (RZLT)United States$0.382B-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63